Tandem Diabetes Care, Inc. (NASDAQ: TNDM)

This investigation is for anyone who acquired securities in Tandem Diabetes Care, Inc. (NASDAQ: TNDM) prior to August 7, 2025.

The Law Offices of Howard G. Smith believes that the Company and certain of its executives violated federal law. Specifically, the Law Offices of Howard G. Smith believes that the Company misled investors regarding its financial condition. More specifically, the Law Offices of Howard G. Smith believes that the Company misled investors by failing to timely inform investors of a product defect in some of the Company’s insulin pumps.

On August 7, 2025, Tandem disclosed that a malfunction had been identified in some of its insulin pumps which could “trigger an error resulting in a discontinuation of insulin delivery” which “could result in hyperglycemia due to discontinuation of insulin delivery” and “may require hospitalization or intervention from a medical professional.” The Company stated that it had sent notices to impacted customers between July 22 and 24, 2025. On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in Tandem Diabetes Care, Inc. (NASDAQ: TNDM) prior to August 7, 2025 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.